| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |